Skip to Content

Cochlear Ltd CHEOF

Morningstar Rating
$222.67 0.01 (< 0.01%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CHEOF is trading at a 34% premium.
Price
$222.77
Fair Value
$899.85
Uncertainty
Medium
1-Star Price
$264.28
5-Star Price
$352.15
Economic Moat
Lgqz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CHEOF is a good fit for your portfolio.

Trading Information

Previous Close Price
$222.68
Day Range
$222.67222.67
52-Week Range
$145.73225.75
Bid/Ask
$209.50 / $230.97
Market Cap
$14.58 Bil
Volume/Avg
25 / 206

Key Statistics

Price/Earnings (Normalized)
60.18
Price/Sales
10.28
Dividend Yield (Trailing)
0.98%
Dividend Yield (Forward)
0.78%
Total Yield
1.12%

Company Profile

Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Large Growth
Total Number of Employees
4,500

Competitors

Valuation

Metric
CHEOF
RMD
SOON
Price/Earnings (Normalized)
60.1826.3123.19
Price/Book Value
12.016.037.81
Price/Sales
10.285.864.54
Price/Cash Flow
51.3521.8221.45
Price/Earnings
CHEOF
RMD
SOON

Financial Strength

Metric
CHEOF
RMD
SOON
Quick Ratio
1.801.230.76
Current Ratio
2.573.111.29
Interest Coverage
50.9719.7129.18
Quick Ratio
CHEOF
RMD
SOON

Profitability

Metric
CHEOF
RMD
SOON
Return on Assets (Normalized)
14.09%14.83%11.96%
Return on Equity (Normalized)
20.32%24.40%30.61%
Return on Invested Capital (Normalized)
17.67%18.31%22.85%
Return on Assets
CHEOF
RMD
SOON
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesLbjxnbp$205.8 Bil
SYK
Stryker CorpRpf$134.3 Bil
MDT
Medtronic PLCMhfd$111.0 Bil
BSX
Boston Scientific CorpMwkqd$98.5 Bil
EW
Edwards Lifesciences CorpVwksjl$51.2 Bil
DXCM
DexCom IncJyj$46.9 Bil
ZBH
Zimmer Biomet Holdings IncVhs$25.4 Bil
ALGN
Align Technology IncSmgbxyx$22.5 Bil
PHG
Koninklijke Philips NV ADRLyvnr$18.4 Bil
PODD
Insulet CorpGwcnxl$11.8 Bil

Sponsor Center